Present and Future of Endoscopic Ultrasound-Guided Tissue Acquisition in Solid Pancreatic Tumors
Clinical Endoscopy
;
: 541-548, 2019.
Article
in English
| WPRIM
| ID: wpr-785671
ABSTRACT
Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is a well-established method for pathological diagnosis of solid pancreatic neoplasm. It can be performed either as EUS-guided fine-needle aspiration (EUS-FNA) or EUS-guided fine-needle biopsy (EUS-FNB). The incidence of adverse events related to EUS-TA is less than 1%. The factors that affect the diagnostic accuracy and specimen adequacy include the techniques used, type and size of the needle, competency of endosonographers, presence of cytopathologists/cytotechnologists, and rapid on-site examination. EUS-TA may contribute to precision medicine through obtaining tissue samples for next-generation sequencing. The current status, several clinical issues for diagnostic yield and adverse events, and future perspectives of EUS-FNA/FNB for diagnosing pancreatic neoplasm have been discussed in this review article.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pancreatic Neoplasms
/
Incidence
/
Biopsy, Fine-Needle
/
Diagnosis
/
Precision Medicine
/
Methods
/
Needles
Type of study:
Diagnostic study
/
Incidence study
/
Prognostic study
Language:
English
Journal:
Clinical Endoscopy
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS